Akari Therapeutics (AKTX) Amortizatization of Intangibles (2015)
Akari Therapeutics' (AKTX) quarterly Amortizatization of Intangibles came in at $19.3 million in Q3 2015.
Akari Therapeutics (AKTX) Amortizatization of Intangibles (2015) Analysis & Trends
Akari Therapeutics has disclosed Amortizatization of Intangibles across 1 years of filings, most recently posting $19.3 million for Q3 2015.
- Amortizatization of Intangibles for Q3 2015 came in at $19.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $19.3 million (changed N/A YoY), and the FY2015 annual result was $19.3 million, changed N/A from the prior year.
- Amortizatization of Intangibles came in at $19.3 million for Q3 2015 at Akari Therapeutics.
- In the past five years, Amortizatization of Intangibles ranged from a high of $19.3 million in Q3 2015 to a low of $19.3 million in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 19.28 Mn |
| Sep 30, 2015 | 19.28 Mn |